An Update on New Anticoagulants

Publisher： Bentham Science Publishers

E-ISSN： 1875-5895|3|4|287-300

ISSN： 1568-0061

Source： Current Drug Targets - Cardiovascular & Hematological Disorders, Vol.3, Iss.4, 2003-12, pp. : 287-300

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rationale for Development of New Oral Anticoagulants

By  

Cardiovascular & Haematological Disorders - Drug Targets(Formerly Current Drug Targets - Cardiovascular & Hematological Disorders), Vol. 15, Iss. 2, 2015-08 ,pp. : 89-91

Bentham Science Publishers

Access to resources Recommend Favorite

Apixaban in Venous Thromboembolism in an Era of New Oral Anticoagulants

By  

Cardiovascular & Haematological Disorders - Drug Targets(Formerly Current Drug Targets - Cardiovascular & Hematological Disorders), Vol. 15, Iss. 2, 2015-08 ,pp. : 139-147

Bentham Science Publishers

Access to resources Recommend Favorite

New Oral Anticoagulants in Coronary Artery Disease

By  

Cardiovascular & Haematological Disorders - Drug Targets(Formerly Current Drug Targets - Cardiovascular & Hematological Disorders), Vol. 15, Iss. 2, 2015-08 ,pp. : 101-105

Bentham Science Publishers

Access to resources Recommend Favorite

The new oral anticoagulants: clinical use and reversal agent development

By  

ISBT SCIENCE SERIES, Vol. 10, Iss. S1, 2015-04 ,pp. : 324-331

John Wiley & Sons Inc

Access to resources Recommend Favorite

New Oral Anticoagulants in Prophylaxis of Venous Thromboembolic Disease in Major Orthopedic Surgery

By  

Cardiovascular & Haematological Disorders - Drug Targets(Formerly Current Drug Targets - Cardiovascular & Hematological Disorders), Vol. 15, Iss. 3, 2015-12 ,pp. : 204-209

Bentham Science Publishers

Access to resources Recommend Favorite